Primenenie ubikhinona (koenzima Q) v kompleksnoy terapii sakharnogo diabeta i ego sosudistykh oslozhneniy
https://doi.org/10.14341/2072-0351-5865
Abstract
About the Authors
Mikhail Ivanovich BalabolkinElena Michailovna Klebanova
Viktoriya Michailovna Kreminskaya
References
1. Bloomgarden Z. T, Developments in diabetes and insulin resistance // Diabetes Care - 2006 - Vol. 29 - P. 161-167
2. International Diabetes Federation: Diabetes Atlas, 2003
3. International Diabetes Federation: Diabetes Atlas, 2006
4. Malaisse W.J., Glucose-sensing by the pancreatic -cell: the mitochondrial part // Int J Biochem - 1992 - Vol. 24 - P.693-701
5. Newgard C.B., McGarry J.D., Metabolic coupling factors in pancreatic -cell signal transduction // Ann Rev Biochem - 1995 - Vol. 64 - P.689-719
6. Hopkins W.F., Fatherazi S., Peter-Riesch B. et al., Two sites for adeninenucleotide regulation of ATP-sensitive potassium channels in mouse -cells and HIT cells // J Membrane Biol - 1992 - Vol. 129 - P. 287-295
7. MacDonald M.J., Fahien L.A., Insulin release in pancreatic islets by a glycolytic and a Krebs cycle intermediate: contrasting patterns of glyceraldehydes phosphate and succinate // Arch Biochem Biophys - 1990 - Vol. 279 - P. 104-108
8. Sener A., Malaisse W.J., Hexose metabolism in pancreatic islets. Ca2+- dependent activation of the glycerol phosphate shuttle by nutrient secretagogues // J Biol Chem - 1992 - Vol. 267 - P. 13251-13256
9. Sener A., Herberg L., Malaisse W.J., FAD-linked glycerophosphate dehydrogenase deficiency in pancreatic islets of mice with hereditary diabetes // FEBS Lett - 1993 - Vol. 40 - P. 224-227
10. Giroix M.H., Rasschaert J., Bailbe D. et al., Impairment of glycerol phoaphate shuttle in islets from rats with diabetes induced by neonatal streptozocin // Diabetes - 1991 - Vol. 40 - P. 227-232
11. Fernandez-Alvarez J., Conget I., Rasschaert J et al., Enzymatic, metabolic and secretory patterns in human islets of type 2 (non-insulindependent) diabetic patients // Diabetologia - 1994 - Vol. 37 - P. 177-181
12. McCarty M.F., Can correction of sub-optimal coenzyme Q status improve -cell function in type II diabetics? // Medical Hypotheses - 1999 - Vol. 52 - P. 397-400
13. McDonnell M.R., Archbold G.P.R., Plasma ubiquinol/cholesterol ratios in patients requiring dialysis // Clin Chim Acta - 1996 - Vol. 91 - P. 10878-10882
14. DeFronzo R.A., Bonadonna R., Ferrannini E., Pathogenesis of NIDDM: a balanced overview // Diabetes Care - 1992 - Vol. 15 - P. 318-368
15. Watts G.F., Playford D., Dislipoproteinemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in NIDDM: an hypothesis // Atherosclerosis - 1998 - Vol. 141 - P. 17-31
16. KimY., Iwashita S., Tamura T. et al., Effect of high-fat diet on the gene expression of pancreatic GLUT2 and glucokinase in rats // Biochem Biophys Res Comm - 1996 - Vol. 208 - P. 1092-1098
17. Andersen C.B., henriksen J.E., Hother-Nielsen O. et al., The effect of coenzyme Q10 onblood glucose and insulin requirement in patients with insulin dependent diabetes mellitus // Mol Aspects Med - 1997 - Vol. 18 - Suppl - P. 307-309
18. Eriksson J.G., Forsen T.J., Mortensen S.A., Rohde M., The effect of coenzyme Q10 administration on metabolic control in patients with type 2 diabetes mellitus // BioFactoes - 1999 - Vol. 9 - P. 315-318
19. Kalen A., Appelkvist E.L., Dallner G., Age-related changes in the lipid compositions of rat and human tissues // Lipids - 1989 - Vol. 24 - P. 579-584
20. Soderberg M., Edlund C., Kristensson K., Dallner G., Lipid composition of different regions of the human brain during aging // J Neurochem - 1990 - Vol. 54 - P. 415-423
21. Greenberg S., Frishman H., Co-enzyme Q10; a new drug for cardiovascular disease // J Clin Pharmacol - 1990 - Vol. 30 - P.596-608
22. Stocker R., Bowry V.W., Frei B., Ubiquinol-10 protects human low-density lipoprotein more efficiently against lipid peroxidation than does -tocopherol // Proc Natl Acad Sci USA - 1991 - Vol. 88 - P. 1646-1650
23. Thomas S.R., Neuzil J., Stocker R., Cosupplementation with coenzymeQ prevents the prooxidant effect of -tocopherol and increase the resistance of LDL to transition metal-dependent oxidation initiation // Arterioscler Thromb Vasc Biol - 1996 - Vol. 16 - P. 687-696
24. Watts G.F., Playford D.A., Croft K.D. et al., Coenzyme Q10 improves endothelial dysfunction of the brachial artery in type II diabetes mellitus // Diabetologia - 2002 - Vol. 45 - P. 420-426
25. Playford D.A., Watts G.F., Croft K.D., Burke V., Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes // Atherosclerosis - 2003 - Vol. 168 - P. 169-179
26. Maebashi M., Makino Y., Furukawa Y. et al., Therapeutic evaluation of the effect of biotin on hyperglycemia in patients with non-insulin dependent diabetes mellitus // J Clin Biochem Nutr - 1993 - Vol. 14 - P. 211-218
27. Bordoni P., Magnaterra R., Rabini R.A. et al., Effect of biotin on glucokinase activity, mRNA expression and insulin release in cultured beta-cells // Acta Diabetol - 1996 - Vol. 33 - P. 154-158
Review
For citations:
Balabolkin M.I., Klebanova E.M., Kreminskaya V.M. Primenenie ubikhinona (koenzima Q) v kompleksnoy terapii sakharnogo diabeta i ego sosudistykh oslozhneniy. Diabetes mellitus. 2007;10(4):37-42. (In Russ.) https://doi.org/10.14341/2072-0351-5865

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).